KIRSTEN HUFF: Open Payments
NPI 1205586112 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 31 payments from 18 companies in 2025. Trend: 2023 $558 · 2024 $127 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 4 | $76 |
| Evofem Biosciences, Inc. | 4 | $66 |
| Dexcom, Inc. | 3 | $57 |
| Sage Therapeutics, LLC | 2 | $41 |
| MILLICENT US INC | 2 | $36 |
| Novo Nordisk Inc | 2 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| SHIELD THERAPEUTICS INC | 2 | $30 |
| Astellas Pharma US Inc | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: Phexxi, Dexcom G6 Transmitter, ZURZUVAE, FEMLYV, MYFEMBREE, ACCRUFER, Veozah, Lynkuet.
Industry payments across MO — which companies pay providers there.
